Response to Controlled Ovarian Stimulation Is Not Impaired in Young Patients with a Sarcoma : Results from a Monocentric Case-Control Study
Sarcomas are relatively common in the young and their treatment can impair fertility. Fertility preservation can be achieved via the cryopreservation of gametes after controlled ovarian stimulation before cancer treatment. A reduced response to hormonal stimulation in patients suffering from certain types of malignancy is reported. The purpose of this study was to assess the performance of oocyte cryopreservation in patients with sarcoma by comparing their outcomes with those of a population without cancer. Patients were matched by age with control women undergoing hormonal stimulation for isolated male factor infertility. The population included 84 women with a sarcoma and 355 controls. In the final analysis, 37 patients with sarcoma were matched in a 1:3 ratio with 109 healthy controls. Patients with sarcoma were generally younger and were stimulated with lower FSH doses. They did not perform worse than controls during stimulation, with an average retrieval of 10.6 oocytes vs. 8.1 in the controls. Linear regression on the number of retrieved mature oocytes confirmed that patients with sarcoma performed comparably to controls. In conclusion, patients with sarcoma can expect retrieval outcomes comparable to those of patients without cancer.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Cancers - 15(2023), 12 vom: 11. Juni |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cioffi, Raffaella [VerfasserIn] |
---|
Links: |
---|
Themen: |
Fertility preservation |
---|
Anmerkungen: |
Date Revised 01.07.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/cancers15123141 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358720621 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358720621 | ||
003 | DE-627 | ||
005 | 20231226075337.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cancers15123141 |2 doi | |
028 | 5 | 2 | |a pubmed24n1195.xml |
035 | |a (DE-627)NLM358720621 | ||
035 | |a (NLM)37370751 | ||
035 | |a (PII)3141 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cioffi, Raffaella |e verfasserin |4 aut | |
245 | 1 | 0 | |a Response to Controlled Ovarian Stimulation Is Not Impaired in Young Patients with a Sarcoma |b Results from a Monocentric Case-Control Study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.07.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Sarcomas are relatively common in the young and their treatment can impair fertility. Fertility preservation can be achieved via the cryopreservation of gametes after controlled ovarian stimulation before cancer treatment. A reduced response to hormonal stimulation in patients suffering from certain types of malignancy is reported. The purpose of this study was to assess the performance of oocyte cryopreservation in patients with sarcoma by comparing their outcomes with those of a population without cancer. Patients were matched by age with control women undergoing hormonal stimulation for isolated male factor infertility. The population included 84 women with a sarcoma and 355 controls. In the final analysis, 37 patients with sarcoma were matched in a 1:3 ratio with 109 healthy controls. Patients with sarcoma were generally younger and were stimulated with lower FSH doses. They did not perform worse than controls during stimulation, with an average retrieval of 10.6 oocytes vs. 8.1 in the controls. Linear regression on the number of retrieved mature oocytes confirmed that patients with sarcoma performed comparably to controls. In conclusion, patients with sarcoma can expect retrieval outcomes comparable to those of patients without cancer | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a fertility preservation | |
650 | 4 | |a oncofertility | |
650 | 4 | |a oocyte cryopreservation | |
650 | 4 | |a ovarian stimulation | |
650 | 4 | |a sarcoma | |
700 | 1 | |a Pagliardini, Luca |e verfasserin |4 aut | |
700 | 1 | |a Quartucci, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Papaleo, Enrico |e verfasserin |4 aut | |
700 | 1 | |a Vanni, Valeria Stella |e verfasserin |4 aut | |
700 | 1 | |a Provenzano, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Bertulli, Rossella |e verfasserin |4 aut | |
700 | 1 | |a Candiani, Massimo |e verfasserin |4 aut | |
700 | 1 | |a Mangili, Giorgia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 15(2023), 12 vom: 11. Juni |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2023 |g number:12 |g day:11 |g month:06 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers15123141 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2023 |e 12 |b 11 |c 06 |